Sacramento, California Local News
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
[ad_1] An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in…
